206 related articles for article (PubMed ID: 15220775)
1. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
Jiang X; Shi E; Nakajima Y; Sato S
Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775
[TBL] [Abstract][Full Text] [Related]
2. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
4. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice.
Xi L; Jarrett NC; Hess ML; Kukreja RC
Circulation; 1999 Apr; 99(16):2157-63. PubMed ID: 10217657
[TBL] [Abstract][Full Text] [Related]
5. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Jiang X; Shi E; Nakajima Y; Sato S
Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
[TBL] [Abstract][Full Text] [Related]
6. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice.
Xi L; Salloum F; Tekin D; Jarrett NC; Kukreja RC
Am J Physiol; 1999 Dec; 277(6):H2418-24. PubMed ID: 10600864
[TBL] [Abstract][Full Text] [Related]
7. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction.
Xi L; Kukreja RC
Toxicology; 2000 Nov; 155(1-3):37-44. PubMed ID: 11154795
[TBL] [Abstract][Full Text] [Related]
8. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
Wang D; Yang XP; Liu YH; Carretero OA; LaPointe MC
Am J Hypertens; 1999 Feb; 12(2 Pt 1):174-82. PubMed ID: 10090345
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.
Imagawa J; Yellon DM; Baxter GF
Br J Pharmacol; 1999 Feb; 126(3):701-8. PubMed ID: 10188982
[TBL] [Abstract][Full Text] [Related]
10. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Patel HH; Hsu AK; Gross GJ
Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
12. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS?
Bell RM; Smith CC; Yellon DM
Cardiovasc Res; 2002 Feb; 53(2):405-13. PubMed ID: 11827691
[TBL] [Abstract][Full Text] [Related]
14. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
Zhang JH; Chen ZW; Wu Z
Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
[TBL] [Abstract][Full Text] [Related]
15. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS.
Zhao TC; Taher MM; Valerie KC; Kukreja RC
Circ Res; 2001 Nov; 89(10):915-22. PubMed ID: 11701619
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
Wildhirt SM; Weismueller S; Schulze C; Conrad N; Kornberg A; Reichart B
Cardiovasc Res; 1999 Aug; 43(3):698-711. PubMed ID: 10690341
[TBL] [Abstract][Full Text] [Related]
17. Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.
West MB; Rokosh G; Obal D; Velayutham M; Xuan YT; Hill BG; Keith RJ; Schrader J; Guo Y; Conklin DJ; Prabhu SD; Zweier JL; Bolli R; Bhatnagar A
Circulation; 2008 Nov; 118(19):1970-8. PubMed ID: 18936326
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice.
Imamura G; Bertelli AA; Bertelli A; Otani H; Maulik N; Das DK
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H1996-2003. PubMed ID: 12003803
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase.
Wang YP; Sato C; Mizoguchi K; Yamashita Y; Oe M; Maeta H
Cardiovasc Res; 2002 Oct; 56(1):33-42. PubMed ID: 12237164
[TBL] [Abstract][Full Text] [Related]
20. Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase.
Wang Y; Xu H; Mizoguchi K; Oe M; Maeta H
Cardiovasc Res; 2001 Feb; 49(2):391-8. PubMed ID: 11164849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
